How does cosentyx impact mmr vaccine's effectiveness?

In general, Cosentyx (secukinumab) can affect how well the immune system responds to vaccines, and MMR is a live attenuated vaccine. Because of that:

- Live vaccines (like MMR) are usually not recommended while you are on Cosentyx. There’s a safety concern about giving a live vaccine when the immune system is suppressed, and the vaccine may not produce a reliable protective response.
- If you’re planning vaccination, most clinicians aim to give the MMR vaccine before starting Cosentyx or to wait until after stopping therapy, depending on your disease activity and exposure risk.
- If you’re already on Cosentyx, a clinician might discuss delaying the MMR vaccine or, in some cases, temporarily stopping Cosentyx. Any decision should be made with your rheumatologist/dermatologist and/or infectious disease specialist.
- Inactivated vaccines (not live) are generally considered safer options for people on immunosuppressive therapy, but the immune response may still be somewhat reduced.

If you’re due for MMR or planning travel/exposure risk, talk to your doctor about:
- Whether you should receive the MMR vaccine now or after a hold on Cosentyx.
- Whether antibody testing (titer) is appropriate to assess immunity.
- The best timing to minimize infection risk while maintaining disease control.

I’m not a substitute for medical advice—please consult your prescriber for guidance tailored to your situation. If you want, tell me your country and current Cosentyx dosing, and I can share more specific guidelines.